KD Logo

The Potential Rise in the Price of Amneal Pharmaceuticals Inc (AMRX) following insiders activity

Amneal Pharmaceuticals Inc’s recent filing unveils that its Director Patel Gautam unloaded Company’s shares for reported $0.5 million on Jan 08 ’25. In the deal valued at $8.01 per share,62,590 shares were sold. As a result of this transaction, Patel Gautam now holds 1,968,886 shares worth roughly $15.46 million.

Then, Patel Gautam sold 17,410 shares, generating $139,454 in total proceeds. Upon selling the shares at $8.01, the Director now owns 2,031,476 shares.

Before that, Gautam J Patel bought 320,000 shares. Amneal Pharmaceuticals Inc shares valued at $2,560,000 were divested by the Director at a price of $8.00 per share.

JP Morgan upgraded its Amneal Pharmaceuticals Inc [AMRX] rating to a Neutral from a an Underweight in a research note published recently. Goldman also remained covering AMRX and has increased its forecast on March 08, 2021 with a “Buy” recommendation from previously “Sell” rating. Guggenheim revised its rating on December 14, 2020. It rated AMRX as “a Buy” which previously was an “a Neutral”.

Price Performance Review of AMRX

On Tuesday, Amneal Pharmaceuticals Inc [NASDAQ:AMRX] saw its stock jump 1.68% to $7.85. Over the last five days, the stock has gained 1.03%. Amneal Pharmaceuticals Inc shares have fallen nearly -0.88% since the year began. Nevertheless, the stocks have risen 44.04% over the past one year. While a 52-week high of $9.48 was reached on 01/08/25, a 52-week low of $5.01 was recorded on 01/07/25. SMA at 50 days reached $8.23, while 200 days put it at $7.53.

Levels Of Support And Resistance For AMRX Stock

The 24-hour chart illustrates a support level at 7.73, which if violated will result in even more drops to 7.62. On the upside, there is a resistance level at 7.92. A further resistance level may holdings at 8.00. The Relative Strength Index (RSI) on the 14-day chart is 46.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.44%. Stochastics %K at 53.52% indicates the stock is a holding.

How much short interest is there in Amneal Pharmaceuticals Inc?

A steep rise in short interest was recorded in Amneal Pharmaceuticals Inc stocks on 2024-12-31, dropping by -1.38 million shares to a total of 3.3 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 4.67 million shares. There was a decline of -41.68%, which implies that there is a negative sentiment for the stock.

Most Popular